City

Bethesda (2)

Seoul (1)

Overall Status

Not yet recruiting (1)

Recruiting (1)

Terminated (1)

Phase

phase 2 (2)

phase 1 (1)

Sponsor

National Cancer Institute (NCI) (2)

Seoul National University Hospital (1)

Collaborator

Asan Medical Center (1)

Samsung Medical Center (1)

Seoul National University Bundang Hospital (1)

Severance Hospital (1)

Intervention

atezolizumab (2)

biopsy (1)

biospecimen collection (1)

computed tomography (1)

magnetic resonance imaging (1)

pazopanib (1)

selinexor (1)

Study Documents

Intervention Type

drug (3)

biological (1)

procedure (1)

Funder Type

NIH (2)

Other (1)

Study Type

Interventional (3)

metastatic alveolar soft part sarcoma

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Locally Advanced Alveolar Soft Part Sarcoma, Metastatic Alveolar Soft Part Sarcoma, Locally Advanced Non Small Cell Lung Cancer

Not yet recruiting

Locally Advanced Alveolar Soft Part Sarcoma
+9 more

Atezolizumab

Bethesda, Maryland

National Institutes of Health Clinical Center

Oct 10, 2023

Advanced Alveolar Soft Part Sarcoma, Advanced Soft Tissue Sarcoma, Metastatic Alveolar Soft Part Sarcoma Trial run by the NCI

Recruiting

Advanced Alveolar Soft Part Sarcoma
+3 more

Atezolizumab
+5 more

Bethesda, Maryland
+1 more

Jan 28, 2023

Metastatic Alveolar Soft Part Sarcoma Trial in Seoul (Pazopanib)

Terminated

Metastatic Alveolar Soft Part Sarcoma

Pazopanib

Seoul, Korea, Republic of

Seoul National University Hospital

Nov 3, 2017